Glovista Investments LLC bought a new position in UBS AG (NYSE:UBS) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 23,479 shares of the bank’s stock, valued at approximately $403,000.
A number of other hedge funds have also modified their holdings of UBS. Mountain Capital Investment Advisors Inc bought a new stake in shares of UBS during the second quarter valued at approximately $118,000. Fiduciary Trust Co. bought a new stake in shares of UBS during the second quarter valued at approximately $136,000. Segantii Capital Management Ltd bought a new stake in shares of UBS during the second quarter valued at approximately $166,000. Oppenheimer & Co. Inc. bought a new stake in shares of UBS during the second quarter valued at approximately $173,000. Finally, Northwestern Mutual Wealth Management Co. grew its holdings in UBS by 36.7% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 10,468 shares of the bank’s stock worth $178,000 after buying an additional 2,809 shares in the last quarter. Institutional investors and hedge funds own 32.00% of the company’s stock.
UBS has been the topic of several research analyst reports. TheStreet raised UBS from a “d” rating to a “c” rating in a research report on Monday, November 27th. ValuEngine cut UBS from a “strong-buy” rating to a “buy” rating in a research report on Friday, September 1st. Zacks Investment Research raised UBS from a “hold” rating to a “buy” rating and set a $19.00 price objective on the stock in a research report on Monday, September 18th. Instinet cut UBS from a “buy” rating to a “neutral” rating in a research report on Sunday, October 1st. Finally, Societe Generale reissued a “hold” rating on shares of UBS in a research report on Monday, October 30th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the company. UBS presently has an average rating of “Hold” and an average price target of $19.00.
Shares of UBS AG (NYSE UBS) traded down $0.13 on Thursday, reaching $16.97. The company had a trading volume of 1,588,500 shares, compared to its average volume of 2,012,489. The stock has a market cap of $65,881.46, a PE ratio of 15.00, a price-to-earnings-growth ratio of 0.87 and a beta of 1.22. The company has a debt-to-equity ratio of 2.46, a current ratio of 1.21 and a quick ratio of 1.21. UBS AG has a twelve month low of $15.10 and a twelve month high of $18.31.
ILLEGAL ACTIVITY NOTICE: “Glovista Investments LLC Takes $403,000 Position in UBS AG (UBS)” was first published by Stock Observer and is owned by of Stock Observer. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The original version of this news story can be viewed at https://www.thestockobserver.com/2017/12/07/glovista-investments-llc-takes-403000-position-in-ubs-ag-ubs.html.
UBS Company Profile
UBS Group AG is a holding company and conducts its operations through UBS AG and its subsidiaries. The Company comprises Corporate Center and five business divisions: Wealth Management, Wealth Management Americas, Personal & Corporate Banking, Asset Management and the Investment Bank. Wealth Management division provides advice and tailored financial services to wealthy private clients around the world, except those served by Wealth Management Americas.
Want to see what other hedge funds are holding UBS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UBS AG (NYSE:UBS).
Receive News & Ratings for UBS AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UBS AG and related companies with MarketBeat.com's FREE daily email newsletter.